- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/06 - Peri-condensed systems
Patent holdings for IPC class C07D 513/06
Total number of patents in this class: 89
10-year publication summary
14
|
10
|
5
|
5
|
6
|
1
|
9
|
16
|
2
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Erasca, Inc. | 85 |
8 |
Merck Patent GmbH | 5831 |
7 |
LG Chem, Ltd. | 17479 |
5 |
Onkure, Inc. | 23 |
4 |
Samsung Display Co., Ltd. | 33816 |
3 |
FUJIFILM Corporation | 29095 |
3 |
Piramal Enterprises Limited | 153 |
3 |
Promega Corporation | 571 |
3 |
Shionogi & Co., Ltd. | 873 |
3 |
Bayer Pharma AG | 1057 |
2 |
Amgen Inc. | 3988 |
2 |
Abbvie Inc. | 1782 |
2 |
Purdue Research Foundation | 3541 |
2 |
Bioimics AB | 3 |
2 |
Council of Scientific and Industrial Research | 595 |
2 |
Gilead Sciences, Inc. | 2013 |
2 |
Sagami Chemical Research Institute | 86 |
2 |
Tosoh Corporation | 1250 |
2 |
Prelude Therapeutics, Incorporated | 124 |
2 |
Samsung Electronics Co., Ltd. | 142415 |
1 |
Other owners | 29 |